Page last updated: 2024-09-03

nifekalant hydrochloride and Recrudescence

nifekalant hydrochloride has been researched along with Recrudescence in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Di, C; Gao, P; Lin, W; Wang, Q; Wu, Y1
Ohnishi, S1
Sugi, K1

Reviews

2 review(s) available for nifekalant hydrochloride and Recrudescence

ArticleYear
[Management of lethal ventricular arrhythmias after cardiac surgery].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60, Issue:7

    Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Catheter Ablation; Humans; Intra-Aortic Balloon Pumping; Postoperative Complications; Pyrimidinones; Recurrence; Tachycardia, Ventricular; Ventricular Fibrillation

2002
[Strategy for cardiac arrhythmias in acute coronary syndrome].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64, Issue:4

    Topics: Amiodarone; Angina, Unstable; Anti-Asthmatic Agents; Aprindine; Atrial Fibrillation; Bepridil; Electric Countershock; Humans; Myocardial Infarction; Potassium Channel Blockers; Pyrimidinones; Recurrence; Syndrome; Tachycardia, Ventricular; Ventricular Fibrillation

2006

Other Studies

1 other study(ies) available for nifekalant hydrochloride and Recrudescence

ArticleYear
Intraprocedural Conversion Efficacy of Intravenous Nifekalant Administration for Persistent Atrial Fibrillation after Pulmonary Vein Isolation.
    International heart journal, 2020, Nov-28, Volume: 61, Issue:6

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cryosurgery; Electric Countershock; Female; Heart Atria; Humans; Infusions, Intravenous; Intraoperative Care; Intraoperative Complications; Male; Middle Aged; Organ Size; Peripheral Nerve Injuries; Phrenic Nerve; Progression-Free Survival; Prospective Studies; Pulmonary Veins; Pyrimidinones; Recurrence; Tachycardia, Ventricular; Treatment Outcome

2020